Navigation Links
AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate
Date:1/12/2009

AIM Pharmakon introduced next generation of health and longevity products with a unique premium quality natural liquid calcium & mineral supplement concentrate. AimCa++DONAN is ideal for the market segments of athletes, women in pre and post-menopausal phases, baby-boomers, and seniors needing extra calcium supplementation. The innovative products of Aim Pharmakon are highly efficacious and an exceptionally high-benefit-to-cost ratio for consumers. API and Global Life Science, LLC USA have a strategic partnership in marketing, project development and project management and Global Life Science will promote AimCa++DONAN (TM) and AimEndurance (TM) globally.

(Vocus) January 12, 2009 -- AIM Pharmakon, Inc. (API), a New York-based company, announced today the introduction of the next generation of health and longevity products with AimCa++DONAN (TM), a new premium quality liquid calcium mineral concentrate for bone development. The product is available directly from AIM Pharmakon, Inc., through the physician care market, in select retail outlets and through its affiliated company Global Life Science, LLC USA. The key components of the product are derived through "Green Technology". The product is eco-friendly, completely natural with specific biophysiological features, bioavailable nutrients, and biodegradable components. Unique product features are- no preservatives, no artificial colors and no artificial flavors. AimCa++DONAN is ideal for the market segments of athletes, women in pre and post-menopausal phases, baby-boomers, and seniors needing extra calcium supplementation.



"The role of calcium in the pathogenesis of osteoporosis is significantly prominent. There is insufficient intake of dietary calcium and mineral in our diet, particularly in thos
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

6

GOOD

Page: 1 2 3 4

Related medicine news :

1. Push-to-Connect In-Line Filters Introduced
2. Managed Compliance Services Program (MCSP) Introduced for Small Healthcare Practitioners
3. New Stretch Mark and Skin Rejuvenation Treatment Introduced to Houston by Dr. Zaniewski-Singh
4. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
5. Groundbreaking Sign Chi Do Stress Management System Introduced by Dr. Anne Borik Now Available to the Public
6. "Campus Alert by VoiceGate" introduced at Internet Telephony(R) Conference and Expo
7. Arizona Patient Protection Act Introduced
8. Chicken pox vaccination should be introduced for children in the UK
9. New Ovarian Cancer Biomarker Research Act Introduced
10. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced
11. National CPR/AED Awareness Week Introduced in Congress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate
AIM Pharmakon Introduced Next Generation of Health and Longevity Products with a Unique Premium Quality Natural Liquid Calcium & Mineral Supplement Concentrate
(Date:7/4/2009)...nt pain and injury, doctors say , , SATU...s are not as young as they used to be, exercise is...s are in order to stay injury-free. , "As bo... themselves from injuries when exercising," Dr. Ra...rthopaedic Surgeons, said in a news release. "A li...
(Date:7/3/2009)...gnise service excellence during National Customer ... London (PRWeb UK) July 3, 2009 -- Companies ...d to celebrate the importance of excellent custome...ice Week - 5-11 October., , ,Employers in all sect...and local authority see the week, which is organis...
(Date:7/3/2009)... in middle age may triple the risk, study shows ,...iddle-aged adults who live alone are twice as like...r in life compared to those who are married or liv...er among those who are divorced or widowed, accord...ers. , The study included 2,000 men and women i...
(Date:7/3/2009).../ -- Sundia MediTech, a leading,integrated pharma...n Shanghai,China announced today that Dr. Chen C...hemistry Services. , Prior to joining Sundi...ug,discovery and development company in San Diego...ior Director of Medicinal Chemistry of Neurocrine....
Breaking Medicine News(10 mins):Health News:Exercise Tips to Keep Boomers on Their Feet 2Health News:Businesses Urged to Sign Up and Celebrate Customer Service 2Health News:Living Alone Increases Odds of Developing Dementia 2Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2
...s at loggerheads with the pharmaceutical industry ... generic medicines. // While Thailand argues it wi...to its citizens, drug companies maintain that the ...and discourages foreign investment. "We were disa...
...e awareness about the ill effects of obesity in ch.../ The game is named as "Body Mechanics," and teach...laying the game. The game begins with an introduc...uro, a Yoda-like wise man. He requests players to ...
...approved by the UAE Ministry of Health (MOH) again...warded with a //prequalification status by the Wor... a vaccine against rotavirus gastroenteritis has r...fication endorses the Rotarix quality, safety and ...
...egulator said it has adopted a positive opinion re...on for Focetria, from Novartis //AG (NVS) Vaccines...demic influenza vaccine, intended for the preventi...eclared pandemic situation, once the pandemic vira...
Other Medicine News:Health News:Drug Companies Hit Out at Thai Generic Drug Scheme 2Health News:WHO Awards Prequalification Status to the First UAE Approved Vaccine 2
(Date:7/3/2009)... -- BioCis Pharma Ltd., a privately,held drug dev...inland,announced positive results from its Phase...am, the company,s novel topical drug for dermatolo...conducted in Finland, included 13,patients with m...ProtoCure,emulsion cream to the affected skin are...
(Date:7/2/2009)... Eisai Co., Ltd. (Headquarters: Tok... Eisai Corporation of North America (Headquarters:...zu) are currently focusing on three clinical devel...icept(R) (donepezil hydrochloride tablets) to furt...e. As progress in those programs has been made, Ei...
(Date:6/30/2009)...-- If you have been eating Garlic to keep the mosq...ere is absolutely no scientific evidence that eati... garlic has plenty of evidence to prove it keeps t...y lawns is not as strange as it seems. Mosquito Ba...s being used successfully by city parks, golf cour...
(Date:6/30/2009)...all/ -- Cephalon, Inc. (Nasdaq: CEPH ) today ann...ug Application (sNDA) to the U.S. Food and Drug Ad...R) (armodafinil) Tablets [C-IV] for the indication...e sleepiness associated with jet lag disorder resu...an acute condition that occurs when a person,s int...
Breaking Medicine Technology:BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 2Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 2Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 3Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH DEVELOPMENT COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO INC 11181 1SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH DEVELOPMENT COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO INC 11181 2SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH DEVELOPMENT COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO INC 11181 3How Long Will the Economic Downturn Affect the Dental Biomaterials Market 3F 11179 1How Long Will the Economic Downturn Affect the Dental Biomaterials Market 3F 11179 2Anesthesia in Youngest Kids May be Linked to Learning Disabilities 40452 1Anesthesia in Youngest Kids May be Linked to Learning Disabilities 40452 2Anesthesia in Youngest Kids May be Linked to Learning Disabilities 40452 3Just Say No To Charcoal 21 New Eco Friendly Alternative Grills Faster Burns Cleaner And Greener 11178 1Just Say No To Charcoal 21 New Eco Friendly Alternative Grills Faster Burns Cleaner And Greener 11178 2
...ass.--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek ...pharmaceutical and,biotechnology companies to be f...treatment for cardiovascular disease. While,angiog...is, Boston,Scientific, Baxter, and Genzyme, among ...w biological therapy for advanced,coronary artery ...
..., N.J., July 05, 2007 /PRNewswire/ -- Results from... open-label, Phase,3 study showed that 77 percent ...ing PREZISTA(TM) (darunavir) 600 mg tablets with,1...optimized,background regimen (OBR) of antiretrovir...00 copies/mL at week 48, compared to 68,percent of...
Other Medicine Technology:BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8
Lab-Reader
Fully automatic NRTL and CE certified microplate reader.
Chameleon is a compact and versatile multilabel microplate reader. The patented optical design allows up to six measurement technologies including liquid scintillation counting, luminescence, absorba
Elisa strip reader for single strips or break-away format. On board software calculates single & multi-point calibration curves, regressions, & a variety of cutoff.
Medicine Products: